Trends in the prevalence of primary drug resistance in pulmonary tuberculosis in France from 1962 to 1970: a national survey.
D000293:Adolescent; D000328:Adult; D000352:Africa, Northern; D000367:Age Factors; D000636:Aminosalicylic Acids / Q000494:pharmacology; D000995:Antitubercular Agents / Q000494:pharmacology* / Q000627:therapeutic use; D003523:Cycloserine / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D004977:Ethambutol / Q000494:pharmacology; D005000:Ethionamide / Q000494:pharmacology; D005006:Ethnicity; D005260:Female; D005602:France; D006801:Humans; D007538:Isoniazid / Q000494:pharmacology; D007612:Kanamycin / Q000494:pharmacology; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000302:isolation & purification; D012293:Rifampin / Q000494:pharmacology; D013307:Streptomycin / Q000494:pharmacology; D013828:Thioacetazone / Q000494:pharmacology; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000382:microbiology; D014756:Viomycin / Q000494:pharmacology
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D007612:Kanamycin; D004977:Ethambutol; D003523:Cycloserine; D013828:Thioacetazone; D005000:Ethionamide; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin; D014756:Viomycin